At the time of writing, Immunic Inc [IMUX] stock is trading at $1.10, up 7.84%. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The IMUX shares have gain 4.76% over the last week, with a monthly amount drifted -13.39%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Immunic Inc [NASDAQ: IMUX] stock has seen the most recent analyst activity on November 25, 2024, when H.C. Wainwright initiated its Buy rating and assigned the stock a price target of $10. On August 27, 2024, B. Riley Securities initiated with a Buy rating and assigned a price target of $6 on the stock. SVB Leerink downgraded its rating to a Mkt Perform but stick to its price target of $5 on October 21, 2022. Aegis Capital started tracking with a Buy rating for this stock on April 15, 2021, and assigned it a price target of $55. In a note dated March 24, 2021, JMP Securities initiated an Mkt Outperform rating and provided a target price of $55 on this stock.
For the past year, the stock price of Immunic Inc fluctuated between $0.97 and $2.11. Currently, Wall Street analysts expect the stock to reach $5 within the next 12 months. Immunic Inc [NASDAQ: IMUX] shares were valued at $1.10 at the most recent close of the market. An investor can expect a potential return of 354.55% based on the average IMUX price forecast.
Analyzing the IMUX fundamentals
To continue investigating profitability, this company’s Return on Assets is posted at -1.5, Equity is -1.78 and Total Capital is -2.31.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 1.0633 points at the first support level, and at 1.0267 for the second support level. However, for the 1st resistance point, the stock is sitting at 1.1233, and for the 2nd resistance point, it is at 1.1467.
Ratios To Look Out For
It is important to note that Immunic Inc [NASDAQ:IMUX] has a current ratio of 2.71. As well, the Quick Ratio is 2.71, while the Cash Ratio is 2.53.
Transactions by insiders
Recent insider trading involved Rudick Richard Alan, Director, that happened on Nov 12 ’24 when 87300.0 shares were purchased.
